The vaginal microbiome — the community of microorganisms inhabiting the reproductive tract — has emerged as a significant fertility variable over the past decade. Research now shows that the composition of vaginal and cervical microbial communities meaningfully affects sperm survival, cervical mucus receptivity, endometrial health, and implantation success. For ICI users, understanding and optimizing the reproductive microbiome is an underappreciated and actionable component of fertility preparation.
Normal vs. Dysbiotic Vaginal Microbiome
A healthy, fertility-supportive vaginal microbiome is dominated by Lactobacillus species — primarily L. crispatus, L. iners, L. jensenii, and L. gasseri. These bacteria produce lactic acid, maintaining a low vaginal pH (3.5–4.5) that is hostile to pathogenic organisms while being supportive of sperm function. Importantly, L. crispatus dominance is associated with the best reproductive outcomes in the literature — better IVF implantation rates, lower rates of preterm birth, and more favorable cervical mucus characteristics. L. iners, while common, is more fragile and associated with transition to dysbiotic states.
Vaginal dysbiosis — typically called bacterial vaginosis (BV) when meeting clinical diagnostic criteria — involves a shift away from Lactobacillus dominance toward a polymicrobial community including Gardnerella vaginalis, Prevotella species, Mobiluncus, and other anaerobes. BV affects approximately 20–30% of reproductive-age women and is significantly more prevalent in Black and Latina women due to complex factors including historical healthcare disparities. BV is associated with reduced IUI and ICI pregnancy rates, increased miscarriage risk, and increased risk of ascending pelvic infections that can cause tubal damage. Screening for and treating BV before beginning ICI cycles has direct clinical relevance.
How the Vaginal Microbiome Affects ICI Specifically
For ICI, where sperm is deposited near the cervical os and must traverse cervical mucus to reach the fallopian tubes, vaginal microbiome composition affects the journey at multiple points. In a Lactobacillus-dominant environment, the acidic pH and bacteriocin production of healthy flora protect sperm from pathogenic organisms while lactic acid at concentrations produced by healthy flora does not impair sperm motility at normal exposure durations. In a dysbiotic environment, enzymes produced by BV-associated bacteria (including sialidases and mucinases) actively degrade the glycoprotein structure of cervical mucus, impairing the sperm-channeling function that fertile mucus provides. This direct enzymatic mucus degradation is one mechanism by which BV reduces ICI success rates independent of infection-related effects.
The endometrial microbiome — a newly characterized and distinct community from the vaginal microbiome — also affects implantation. A 2019 study in AJOG found that non-Lactobacillus dominated endometrial microbiomes were associated with significantly reduced IVF implantation and pregnancy rates. While endometrial microbiome assessment is not yet standard clinical practice for ICI patients, the finding reinforces the importance of treating vaginal dysbiosis before beginning cycles — ascending organisms from the vagina are one route by which the endometrial microbiome is seeded, and treating vaginal dysbiosis may reduce non-Lactobacillus endometrial colonization.
Diagnosis and Treatment of Vaginal Dysbiosis
Vaginal dysbiosis ranges from asymptomatic (detected only on testing) to symptomatic BV (characterized by thin gray-white discharge, fishy odor particularly after intercourse, and vaginal pH above 4.5). Asymptomatic dysbiosis is particularly relevant for ICI candidates because the absence of symptoms does not indicate a healthy microbiome — studies show 50–75% of women with microbiome testing-confirmed dysbiosis have no symptoms. Comprehensive vaginal microbiome testing (from companies like Evvy, Phosphorus, or Juno Bio) provides speciated analysis of vaginal flora rather than the diagnostic threshold approach of clinical BV testing, and is increasingly accessible at $99–$199 direct-to-consumer.
Standard BV treatment is oral metronidazole 500 mg twice daily for 7 days or vaginal metronidazole 0.75% gel daily for 5 days. Recurrence rates are high — approximately 50–70% within 6 months — because antibiotic treatment eliminates BV-associated bacteria but does not reseed protective Lactobacillus. Probiotic recolonization after antibiotic treatment, using vaginal probiotics containing L. crispatus or L. rhamnosus strains (Lacto-Fem, RepHresh Pro-B), may reduce recurrence rates. Boric acid vaginal suppositories (600 mg nightly for 14 days) are used for recurrent or refractory BV and for vaginal pH normalization when BV thresholds are not met but pH is above the Lactobacillus-dominant range.
Optimizing the Vaginal Microbiome for ICI
Practical steps for optimizing vaginal microbiome before beginning ICI cycles include: vaginal microbiome testing at baseline (if accessible) to characterize your starting state, treatment of documented BV or dysbiosis before cycling, probiotic support with evidence-based vaginal Lactobacillus strains during and after treatment, and avoiding microbiome-disruptive practices including vaginal douching (strongly discouraged by ACOG — it increases BV risk and removes protective flora), spermicidal lubricants (avoid all lubricants near the time of insemination except those specifically designed as fertility-safe, such as Pre-Seed), and unnecessary antibiotic exposure.
Dietary factors that support Lactobacillus dominance include: fermented foods (yogurt, kefir, sauerkraut, kimchi) that provide oral Lactobacillus to the gut microbiome, which communicates bidirectionally with the vaginal microbiome; adequate fiber intake to support a gut environment conducive to Lactobacillus; and limiting processed sugars that may fuel dysbiotic organisms. While dietary modification alone will not resolve documented dysbiosis, it creates a more supportive environment for the microbiome recolonization that follows treatment — making dietary optimization a meaningful complementary strategy alongside targeted antimicrobial and probiotic interventions.
For a complete at-home insemination solution, the MakeAmom Babymaker Kit includes everything you need for a properly timed, sterile ICI cycle. For a complete at-home insemination solution, the His Fertility Boost includes everything you need for a properly timed, sterile ICI cycle.
Further reading across our network: IntracervicalInsemination.org · MakeAmom.com
This article is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making decisions about your fertility care.